Zobrazeno 1 - 10
of 12
pro vyhledávání: '"G M, Hirschfield"'
Autor:
C G Plagiannakos, A J Montano-Loza, E Lytvyak, J Pallotta, A L Mason, K M Qumosani, L Worobetz, J A Flemming, J Hercun, C Vincent, A Cheung, T Chen, D Grbic, M G Swain, A Gulamhusein, B E Hansen, G M Hirschfield
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:24-25
Background We sought to understand how the demographics of autoimmune hepatitis (AIH) have changed over time in Canada. Purpose Using a large multi-centre Canadian cohort of patients with AIH, we describe the trends in patient and disease characteris
Autor:
K Zheng, F Onofrio, C Xu, S Chen, W Xu, M Vyas, K Bingham, K Patel, L Lilly, N Selzner, E Jaeckel, C Tsien, A Gulamhusein, G M Hirschfield, M Bhat
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:23-24
Background Liver transplantation is frequently lifesaving for people living with primary sclerosing cholangitis (PSC). However, patients are waitlisted for liver transplant (LT) according to the MELD-Na score, which may not accurately reflect the bur
Autor:
H Leibovitzh, S Nayeri, K Borowski, C Hernandez-Rocha, S H Lee, W Turpin, J Stempak, I Sandhu, R Milgrom, M I Smith, K Croitoru, G M Hirschfield, A Gulamhusein, M S Silverberg
Publikováno v:
Journal of Crohn's and Colitis. 16:i173-i174
Background Primary sclerosing cholangitis associated Inflammatory bowel disease (PSC-IBD) carries significant morbidity risk. Alterations in bile acid profiles has been shown to modulate chronic inflammation in IBD, but data in PSC-IBD comorbidity is
Autor:
R. Liberal, Y. S. de Boer, R. J. Andrade, G. Bouma, G. N. Dalekos, A. Floreani, D. Gleeson, G. M. Hirschfield, P. Invernizzi, M. Lenzi, A. W. Lohse, G. Macedo, P. Milkiewicz, B. Terziroli, B. van Hoek, J. M. Vierling, M. A. Heneghan, on behalf of the International Autoimmune Hepatitis Group (IAIHG), A. Pares, A. J. Montano-Loza, A. Granito, A. E. Kremer, C. Schramm, C. Lammert, E. L. R. Cancado, E. Bjornsson, F. Lammert, G. M. Hirschflield, H. Hofer, I. Mackay, J. Neuberger, J. P. H. Drenth, C. M. J. van Nieuwkerk, L. Muratori, M. Swain, M. Heneghan, M. Zeniya, O. Chazouilleres, P. Gines, R. Chapman, T. Berg, H. van Buuren, X. Ma
Publikováno v:
Liberal, R, de Boer, Y S, Andrade, R J, Bouma, G, Dalekos, G N, Floreani, A, Gleeson, D, Hirschfield, G M, Invernizzi, P, Lenzi, M, Lohse, A W, Macedo, G, Milkiewicz, P, Terziroli, B, van Hoek, B, Vierling, J M, Heneghan, M, Pares, A, Montano-Loza, A J, Granito, A, Kremer, A E, Floreani, A, Lohse, A W, van Hoek, B, Terziroli, B, Schramm, C, Lammert, C, Cancado, E L R, Bjornsson, E, Lammert, F, Dalekos, G N, Bouma, G, Hirschflield, G M, Macedo, G, Hofer, H, Mackay, I, Neuberger, J, Vierling, J M, Drenth, J P H, van Nieuwkerk, C M J, Muratori, L, Lenzi, M, Swain, M, Heneghan, M, Zeniya, M, Chazouilleres, O, Gines, P, Milkiewicz, P, Andrade, R J, Ma, X & the International Autoimmune Hepatitis Group (IAIHG) 2017, ' Expert clinical management of autoimmune hepatitis in the real world ', Alimentary Pharmacology and Therapeutics, vol. 45, no. 5, pp. 723-732 . https://doi.org/10.1111/apt.13907
Alimentary Pharmacology and Therapeutics, 45(5), 723-732
Alimentary Pharmacology & Therapeutics, 45, 723-732
Alimentary Pharmacology & Therapeutics, 45, 5, pp. 723-732
Alimentary Pharmacology and Therapeutics, 45(5), 723-732
Alimentary Pharmacology & Therapeutics, 45, 723-732
Alimentary Pharmacology & Therapeutics, 45, 5, pp. 723-732
none 55 si First published: 22 December 2016 Background: High-quality data on the management of autoimmune hepatitis (AIH) are scarce. Despite published guidelines, management of AIH is still expert based rather than evidence based. Aim: To survey ex
Autor:
E K K, Henriksen, M K, Viken, M, Wittig, K, Holm, T, Folseraas, S, Mucha, E, Melum, J R, Hov, K N, Lazaridis, B D, Juran, O, Chazouillères, M, Färkkilä, D N, Gotthardt, P, Invernizzi, M, Carbone, G M, Hirschfield, S M, Rushbrook, E, Goode, C Y, Ponsioen, R K, Weersma, B, Eksteen, K K, Yimam, S C, Gordon, D, Goldberg, L, Yu, C L, Bowlus, A, Franke, B A, Lie, T H, Karlsen
Publikováno v:
HLA, 90(4), 228-233. Wiley-Blackwell
HLA, 90(4), 228-233. Wiley
HLA
HLA, 90(4), 228-233. Wiley
HLA
Primary sclerosing cholangitis (PSC) is strongly associated with several human leukocyte antigen (HLA) haplotypes. Due to extensive linkage disequilibrium and multiple polymorphic candidate genes in the HLA complex, identifying the alleles responsibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d097f848955a532f2f2f76288454a470
https://pure.amc.nl/en/publications/hla-haplotypes-in-primary-sclerosing-cholangitis-patients-of-admixed-and-noneuropean-ancestry(58bba8e0-5bf7-4583-b32f-10090ddcb41c).html
https://pure.amc.nl/en/publications/hla-haplotypes-in-primary-sclerosing-cholangitis-patients-of-admixed-and-noneuropean-ancestry(58bba8e0-5bf7-4583-b32f-10090ddcb41c).html
Publikováno v:
Transplant Infectious Disease
Toxoplasmosis may be transferred by organ transplantation. The most common clinical presentation is with multisystem disease, although isolated ocular toxoplasmosis has been described. Many centers have suggested that universal use of co‐trimoxazol
Autor:
G J, Webb, G M, Hirschfield
Publikováno v:
Journal of autoimmunity. 66
Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) represent the three major hepatic autoimmune conditions. Patient morbidity and mortality remain high across these three diseases, and an unmet need f
Publikováno v:
Journal of Autoimmunity
Primary biliary cirrhosis (PBC), a classic autoimmune liver disease, is characterised by a progressive T cell predominant lymphocytic cholangitis, and a serologic pattern of reactivity in the form of specific anti-mitochondrial antibodies (AMA). CD4+
Autor:
M B, Pepys, G M, Hirschfield
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 2(11)
C-reactive protein (CRP), the classical acute phase reactant, has for some time contributed to both the diagnosis and management of a wide range of infective and inflammatory conditions. More recently with the advent of high sensitivity assays, the h
Autor:
M B, Pepys, G M, Hirschfield
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 2(3)
Circulating concentrations of C-reactive protein (CRP), the classical acute phase protein and sensitive systemic marker of inflammation, significantly predict atherothrombotic events and outcome after acute myocardial infarction, demonstrating the ke